ABSTRACT For randomised population trials the unit of randomisation is normally the individual person. In some situations, however, investigators take other groups as basic unit and one such design is cluster randomisation. Considerable attention has been given to this design recently in statistical and epidemiological literature. The Edinburgh randomised trial of breast cancer screening is an example which takes general practices as clusters of patients. The experience of this trial is reported here. Mortality from all causes, cardiovascular disease and lung cancer over the first 5 year period of follow up are examined. We found that spurious mortality differences were present in the analyses, which do not allow for socio-economic status. From examination ofmethods of adjusting for this, we conclude that allowance can be made at the analysis stage, and it is intented that this approach will be adopted when breast cancer mortality is analysed in the Edinburgh trial. Nevertheless, we recommend that for future studies with outcome related to socio-economic status, randomisations which use this design be stratified by socio-economic criteria where this is feasible.
For controlled trials statistical considerations suggest individual randomisation as the method of choice. There are some situations, however, where it is desirable or even essential to take a group or "cluster" as the basic unit. The statistical effect ofsuch sampling is to weaken the efficiency of the randomisation since the effective sample size is considerably smaller. Thus unanticipated differences are more likely to arise between the randomised groups, and these, if undetected, could bias the results.
The use of cluster randomisation as a design for non-therapeutic intervention trials has received considerable attention recently in the epidemiological' 2 and statistical3-7 literature. This work has been concentrated in the USA and relates primarily to cardiovascular disease. The main thrust of the arguments has been that these designs are valid, but that the effective sample size is reduced and that any analysis must take account of between cluster variation, otherwise spurious significance may result.
At the outset Cornfield3 stated that "randomisation by cluster accompanied by an analysis appropriate to randomisation by group is an exercise in self deception.. .". Less attention has been paid to the possibility of bias in the randomisation though Donner and Donald7 discuss a design with matching of background factors before randomising so as to avoid this problem. The aim of this study is to examine the experience of one UK trial which adopted cluster randomisation as its design. The Edinburgh randomised trial of breast cancer screening8 is based on randomisation of the general practices. Five years of follow up have been completed. Breast cancer mortality will be compared between the screened and control populations for the first time when 7 years of follow up have been completed. Meanwhile it has been shown9 that there is a statistically significant relationship between the socio-economic status of the GP practice and all cause mortality amongst its women. This study begins by examining how unexpected differences in the socioeconomic status of the GPs in the screening and control arms of the trial can affect comparisons of mortality from broad disease categories. Methods of adjusting for these effects at the analysis stage are then considered. There has been no examination of breast cancer mortality because it was agreed8 that the first such analysis would be after 7 years of follow up.
Methods
Most women between the ages of 45 and 64 who were resident in Edinburgh between 1978 At the time of randomisation two adjustments were made: practices subsequently found to be operating from the same building were allocated the same status; thus in at least two cases re-allocation of status was made with a screening practice and a control practice from the same size stratum exchanging status. The practices were all visited (MMR) to discuss their status, and control practices in two buildings were inadvertently told that they had been selected for screening. The new status was allowed to stand. One practice selected for screening refused to participate in the trial. In all these cases the changes occurred before any women entered the study.
In order to enlarge the study a similar procedure was used to select 16/44 practices in North Edinburgh for screening in 1980.
The practices were entered into the study one at a time during the period 1979-81. As the practice was entered, all women on the list of the appropriate age were entered. Thereafter, each practice was reviewed annually and women newly on its list or who had recently attained the age of45 were entered. In all cases each woman took her survey entry date or "date of randomisation" from the date when her practice entered the study or was reviewed.
A difficulty we encountered was that GP practices are not fixed entities. They split and amalgamate as doctors retire. There was a time lag between the decision to enter a practice and the completion ofits register. In one case a control practice ceased to exist during this period. It had been amalgamated with a practice-already entered as a screening practice and so the women on its list entered the screening arm of the trial.
Amalgamation and splitting of practices which occurred after they had entered the trial is ignored for the purpose of the trial. "Practices" as they existed at the relevant time in the period 1979-81 are allocated study numbers and each woman belongs to one such "practice". For the most part these are of course actual general practices.
At the beginning of 1981, after all practices in North and South Edinburgh had been allocated their status, it was decided that the screening arnt of the trial was too small. The control practices were stratified as before and three from the largest stratum randomly selected. For Mortality is analysed by logistic regression, modified by the method of Williams'2 to permit extra binomial variation. The hope was that.although the randomisation was by general practice the result would be essentially equivalent to individual randomisation and could be analysed as such. Then mortality rates in the screened population as a whole are compared with those in the control population. An alternative, and for this design technically more correct, approach is to derive mortality rates in each of the general practices and then to compare these. These two are reported here and referred to as individual and cluster randomisation. Each is then repeated with allowance made for social class: more precisely, the personal randomisation method of analysis is stratified by socio-economic category and the cluster randomisation method uses socio-economic status as a continuous covariate. Mortality differences are expressed as a ratio. This is the ratio of mortality rates in the control population to those in the screened population calculated under the assumption that this ratio is not dependent on the covariates (see 13).
Any difference in all cause mortality or mortality from the three broad categories must be a chance result or the consequence of differences between the two arms of the trial other than the intervention. Our aim has been to see whether this does occur and if so, whether the methods described above correct the results.
Results
The numbers of women years in the 5 year period for each arm of the trial and each socio-economic category are shown in table 2. They confirm our impression that there are substantial differences between the two, with the screening population containing many women in the higher socio-economic status. On the other hand table 3 shows that the age distribution in the two populations is almost identical.
The numbers of deaths over the same 5 year period are given in table 4. The numbers are higher in the control population for all cause mortality and for each of the disease categories; after allowing for the difference in population size the total deaths in the control population exceed those in the screening population by 20%. The difference is calculated after allowing for difference in population size.
The mortality data were formally analysed with stratification only by age. This is how we would have anticipated analysing breast cancer mortality. The results are shown in table 5. The differences between the two populations are statistically highly significant for all cause mortality and for cardiovascular disease mortality. Those for lung cancer just attain statistical significance. The two methods of analysis yield almost identical results. Table 6 gives the mortality rates for each socioeconomic category, and the figure shows the rates for each practice plotted against socio-economic status. These show a trend within each population towards higher mortality rates for lower socio-economic status. The formal analysis was therefore repeated with allowance for socio-economic category and status. The results are shown in table 7. For the individual randomisation method statistically significant differences between the populations remain, though the estimate of the rate ratios are considerably reduced. With cluster randomisation method the differences are no longer statistically significant. Freda Alexander, M Maureen Roberts, Walter Lutz, and Wilma Hepburn heterogeneous.'4 Though general practice lists are certainly heterogeneous to some degree, it has been shown9 that socio-economic differences between them can be identified using census data. We have shown here that there are substantial socio-economic status differences between the two arms of the Edinburgh trial. It may have been peculiarly unfortunate or alternatively there may be aspects of its design which are partly responsible; for this reason we have provided full details of the randomisation. The inference is that an apparently large trial can, if randomised in this way, have important differences between the randomised groups.
Randomisation ofgeneral practices is the method of choice for studies where the subjects are general practices. This is not our present concern. We have endeavoured to compile a list of all UK studies with general practices as sampling units, where the target population is all persons (satisfying certain criteria) on the GP lists. Despite having assistance from the Association of University Teachers of General Practice we have found only a small number'S8 in addition to our own. These are a survey of cardiovascular disease, and studies of the care of pre-terminally ill patients with solid cancers, of promoting heart disease prevention in primary care, and of the efficacy of common drugs in primary care. One reason for this design is that GPs and their lists provide an appropriate and readily available sampling frame. Random selection of practices can enable a broad sweep of a national population to be made at relatively small cost. 5 Nevertheless we found that the majority of studies, even of community based intervention, which used this sampling frame took the lists ofa/l participating practices and aplied methods of individual sampling to persons (eg 'I) or families (eg 21 22) or households (eg 23). The main reason for this design (or one using the doctor as randomisation unit) is to study the effect or the implementation of a preventive procedure or a modification of primary care management. If this involves a change in behaviour of a doctor to all patients then individual randomisation is not possible. If other staff in the practice are involved or if there is concern about contamination between the lists of different partners in a practice then the entire list from each practice must be assigned to the same study group. A study of this type tends to use the randomised design we have been discussing'6 7 though in at least one instance the practices were matched'8; it is of interest that though socio-economic factors featured in the matching criteria subsequent correspondence recommended randomisation rather than matching.24
Because general practice lists are not always up to date any use of them to provide population denominators would be suspect. None of the studies we have cited"-" use these. In our own study considerable effort has been put into correcting the lists before they were used as a register of the study population. This involves removing from the denominator duplicate names and those of women who had left Edinburgh or who had died before their entry to the trial. This will be described elsewhere; for the present we would point out that the only difference between the treatment ofthe denominators for the two populations is that the screening invitation system provides one extra method of pruning the denominator for the screening population. This could bias our observed mortality rates but in the opposite direction to the differences that we have found.
The reasons that the Edinburgh trial adopted this design have been described. An important reason was the assumption that individual randomisation would be unacceptable to general practitioners and their patients. It is interesting that the organisers of studies of other kinds of screening22 23 have not had this opinion. Examples of group randomisation abroad include those involving screening for hypertension using general practices as cluster (eg 2 ), dietary intervention using hospitals as clusters (eg 26) and water fluoridation using large geographical communities as clusters27. This design is undoubtedly not common; our experiences indicate that individual randomisation should not be abandoned without good reason. Nevertheless, there will continue to be situations where other considerations are of overriding importance. When this design is adopted then we would recommend that the randomisation be stratified by socio-economic criteria. Census data of this type were ofcourse not available to us at that time. Since post codes were still not nested within enumeration districts in England and Wales in 1981 such census data are still not available to our English colleagues.
Since it is well known that socio-economic factors are associated with mortality and morbidity differences28 it is likely that the socio-economic differences could lead to biased results. The two randomised trials of breast screening which have already reported29 30 were both able to demonstrate almost identical all cause mortality in the two arms of their studies. It has already been shown9 31 that the socio-economic indices which we have attached to individual GP practices are significantly associated with mortality rates. Now in this study it has been demonstrated that if the data were analysed without any adjustment for socio-economic factors spurious conclusions would follow. The intervention which is offered here can have no effect on mortality from all causes, cardiovascular disease or lung cancer and yet substantial differences have been found; these are statistically significant. Had this been a trial of, for example, screening for lung cancer there would have been a distinct possibility of a false result.
Thus the second conclusion of this study is that in a study of this type differences in socio-economic status must be regarded as a real possibility; we have demonstrated a viable method of checking whether this has occurred. At least one of the other studies'5 is currently being checked using census data,32 and another'6 is collecting personal socio-economic data33 so that comparisons can be made.
Our methods of adjusting for the differences have proved satisfactory, though only when using the approach which respects the randomisation units. Thus we may conclude firstly that in this sort of situation it is necessary, as Cornfield indicated,3 to analyse with the GP practice as basic unit, and secondly that with this approach it is possible to adjust successfully for large differences between the populations. Though this is the case we would nevertheless recommend stratified randomisation. It is interesting that the first published account using randomisation between rather than within groups appears to be the "factories" trial of CHD intervention.34 This used a stratified randomisation, since factories were first arranged in pairs, matched according to size, area and nature of industry; within each pair one was randomly allocated to intervention. This is the design discussed by Donner and Donald.7 Finally there is the question of which outcomes will require this adjustment. The Black report28 suggests that almost any morbidity or mortality outcome might do so. In a recent Edinburgh study25 it has been confirmed that for breast cancer there is no evidence of an association of higher mortality with lower socioeconomic status. Indeed there is some evidence of an association in the opposite direction. Nevertheless we would emphasise that these results indicate that an analysis of the Edinburgh randomised trial of breast cancer screening which does not adjust for socioeconomic status is likely to be biased. The above considerations suggest that the bias will be small and conservative. The intention is that the methods presented here will be adopted in that analysis. We believe that it is important to place this decision on record before the breast cancer mortality data are examined. With hindsight we believe it is to be regretted that this trial could not use individual randomisation or group randomisation stratified by socio-economic status. However neither was practicable in 1978 and the former was also believed to be unacceptable. Therefore all the authors, whether involved at the design stage or not, agree that the design decision was inevitable at the time.
problem of social class bias. 
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